Martin Auster
Stock Analyst at Raymond James
(4.21)
Main Sectors:
29 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
DYN Dyne Therapeutics | Upgrades: Strong Buy | 31 35 | 13.06 | 167.99% | 2 | Aug 25, 2025 | |
ALNY Alnylam Pharmaceutic... | Reiterates: Outperform | 370 424 | 456.35 | -7.09% | 2 | Aug 1, 2025 | |
BMRN Biomarin Pharmaceuti... | Initiates Coverage On: Buy | 120 | 55.43 | 116.49% | 2 | Sep 18, 2023 | |
RARE Ultragenyx Pharmaceu... | Upgrades: Outperform | 99 105 | 31.21 | 236.43% | 7 | Mar 16, 2022 | |
ARNA Arena Pharmaceutical... | Downgrades: Neutral | 98 100 | n/a | n/a | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 17 | n/a | n/a | 3 | Apr 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | n/a | n/a | 1 | Apr 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 26 | 9.22 | 182% | 1 | Mar 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 105 120 | 5.9 | 1933.9% | 4 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 725 300 | 3.82 | 7753.4% | 2 | Mar 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 49 58 | 25.56 | 126.92% | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 169 196 | 453.07 | -56.74% | 4 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 62 98 | 2.18 | 4395.41% | 2 | Feb 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 60 | 157.16 | -61.82% | 2 | Jan 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 65 | 37.47 | 73.47% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 156 73 | 22.64 | 222.44% | 4 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 2 | Dec 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 76 78 | 54.92 | 42.02% | 1 | Nov 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 133 | n/a | n/a | 2 | Oct 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 27 43 | 9.57 | 349.32% | 2 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 225 | n/a | n/a | 1 | Oct 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 134 135 | n/a | n/a | 4 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 34 | 46.97 | -27.61% | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 19 21 | 19.96 | 5.21% | 1 | Jun 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 16 | 30.94 | -48.29% | 1 | May 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 38 | n/a | n/a | 3 | Dec 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 80 53 | n/a | n/a | 3 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Apr 12, 2018 |